Singapore markets closed

Atea Pharmaceuticals, Inc. (AVIR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.9200+0.0200 (+0.51%)
At close: 04:00PM EDT
3.9200 0.00 (0.00%)
After hours: 04:02PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-163,658
-135,956
-115,909
121,190
-10,947
-
Depreciation & amortisation
416
416
260
29
19
-
Stock-based compensation
49,479
49,428
46,718
39,621
7,457
-
Change in working capital
34,200
16,163
-46,586
-247,845
300,205
-
Accounts receivable
-
-
-
-
-5,815
0
Accounts payable
20,437
1,701
-1,983
10,289
-488
-
Other working capital
-95,410
-85,395
-122,925
-87,009
296,708
-
Net cash provided by operating activities
-95,410
-85,395
-120,982
-87,005
296,734
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-1,943
-4
-26
-2
Purchases of investments
-572,932
-562,362
-545,352
0
0
-
Sales/maturities of investments
645,557
602,665
91,885
0
0
-
Net cash used for investing activities
72,625
40,303
-455,410
-4
-26
-
Cash flows from financing activities
Common stock issued
-
-
230
1,465
317,632
0
Other financing activities
-
-
-
-
-
-15
Net cash used provided by (used for) financing activities
242
257
370
1,465
531,748
-
Net change in cash
-22,543
-44,835
-576,022
-85,544
828,456
-
Cash at beginning of period
183,453
188,658
764,680
850,224
21,768
-
Cash at end of period
160,910
143,823
188,658
764,680
850,224
-
Free cash flow
Operating cash flow
-95,410
-85,395
-120,982
-87,005
296,734
-
Capital expenditure
-
-
-1,943
-4
-26
-2
Free cash flow
-95,410
-85,395
-122,925
-87,009
296,708
-